The Committee for Justice writes in support of the FY2025 Appropriations Bill’s provisions related to the Federal Trade Commission (FTC).

One particular area that enchants the Khan FTC is the nexus of antitrust and intellectual property.

CFJ's 5th Circuit amicus brief opposes the FTC’s attempt to block a merger between Illumina and Grail, maker of a breakthrough cancer test.

Rivals and their relative power should not be the agency’s main focus. This case demonstrates how the FTC has strayed far from its mission.

Last November, the Federal Trade Commission accepted comments on its proposal to start a rulemaking related to "Commercial Surveillance"...

It (was) almost Festivus. And in 2022, when it comes to the topic of antitrust, the rest of us have more grievances than ever to air.

It (was) almost Festivus. And in 2022, when it comes to the topic of antitrust, the rest of us have more grievances than ever to air.This ev

CFJ's Director of Public Policy, Ashley Baker, will serve as a panelist at the SMU Science & Technology Law Review Symposium

This panel discusses key take-aways from the oral argument and implications for administrative litigation at the Federal Trade Commission...